Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Global Avian Influenza Clinical Trials Review, H2, 2016 - Analysis, Technologies & Forecasts Report - Vendors: Novartis, AstraZeneca, Nanotherapeutics - Research and Markets

Research and Markets
Posted on: 08 Nov 16

Research and Markets has announced the addition of the "Avian Influenza Global Clinical Trials Review, H2, 2016" clinical trials to their offering.

The clinical trial report, Avian Influenza Global Clinical Trials Review, H2, 2016" provides an overview of Avian Influenza clinical trials scenario. This report provides top line data relating to the clinical trials on Avian Influenza. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe.

The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Clinical Trial Reports are generated using Our proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Scope:

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Companies Mentioned:

  • GlaxoSmithKline Plc
  • Novartis AG
  • Johnson & Johnson
  • Microgen Scientific Industrial Company for Immunobiological Medicines
  • AstraZeneca Plc
  • Nanotherapeutics, Inc.
  • Sanofi
  • Mitsubishi Tanabe Pharma Corporation
  • Baxter International Inc.
  • Accelovance Inc.

For more information about this clinical trials report visit http://www.researchandmarkets.com/research/7f5874/avian_influenza

View source version on businesswire.com: http://www.businesswire.com/news/home/20161108006029/en/

Business Wire
www.businesswire.com

Last updated on: 08/11/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.